Trimigan is an antimigraine drug in tablet form, containing the active substance almotriptan . The drug is used for the short-term treatment of headache with acute migraine attacks with or without aura.
Indications
Trymigan is indicated for the acute treatment of headache during migraine attacks with or without aura.
Composition
- The active substance is almotriptan (Almotriptani malas).
- Each film-coated tablet contains 12.5 mg of almotriptan (Almotriptanum) in the form of almotriptan malate.
- Excipients: Tablet core: mannitol; microcrystalline cellulose; sodium starch glycolate; povidone; sodium stearyl fumarate. Tablet coating: hypromellose (E 464); titanium dioxide (E 171); macrogol.
Storage
Store at a temperature below 25°C, in a dry place, out of reach of children.
Avis
Il n’y a pas encore d’avis.